Boston Scientific
878 hedge funds and large institutions have $48.1B invested in Boston Scientific in 2022 Q2 according to their latest regulatory filings, with 80 funds opening new positions, 326 increasing their positions, 320 reducing their positions, and 92 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 14 → 21 (+7)
1.15% more ownership
Funds ownership: 90.11% → 91.26% (+1.1%)
2% more repeat investments, than reductions
Existing positions increased: 326 | Existing positions reduced: 320
0% less call options, than puts
Call options by funds: $312M | Put options by funds: $313M
3% less funds holding
Funds holding: 904 → 878 (-26)
13% less first-time investments, than exits
New positions opened: 80 | Existing positions closed: 92
15% less capital invested
Capital invested by funds: $56.8B → $48.1B (-$8.74B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$303M |
| 2 |
Newport Trust Company
Washington,
District of Columbia
|
+$295M |
| 3 |
Ninety One (UK)
London,
United Kingdom
|
+$253M |
| 4 |
Morgan Stanley
New York
|
+$250M |
| 5 |
Millennium Management
New York
|
+$204M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$617M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$190M |
| 3 |
Two Sigma Investments
New York
|
-$144M |
| 4 |
Goldman Sachs
New York
|
-$140M |
| 5 |
Two Sigma Advisers
New York
|
-$126M |
BSX Hedge Fund Activity: Q2 2022 in Review
878 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q2 2022, worth a combined $48.1B — down 15% from $56.8B a quarter earlier.
Sellers outnumbered buyers: 92 funds closed out of BSX and 80 opened new positions — a net loss of 12 holders — while 320 trimmed existing stakes and 326 added.
The largest buyer was Ameriprise, adding an estimated $303M. The largest seller was Fidelity Investments, cutting an estimated $617M.
- 878 institutional investors held Boston Scientific (BSX) as of Q2 2022, down from 904 in Q1 2022.
- Funds reported $48.1B of Boston Scientific stock for Q2 2022, down 15% quarter-over-quarter.
- 80 funds opened new Boston Scientific positions in Q2 2022 and 92 closed out, a net change of -12 holders.
- The largest Boston Scientific buyer in Q2 2022 was Ameriprise, an estimated $303M added.
- The largest Boston Scientific seller in Q2 2022 was Fidelity Investments, an estimated $617M sold.
Based on aggregated 13F filings for Q2 2022.